This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: SHCBP1 promotes papillary thyroid carcinoma carcinogenesis and progression through promoting formation of integrin and collagen and maintaining cell stemness
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related gene regulation · Cancer, Lipids, and Metabolism
The journal retracts the 26 February 2021 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Editors of Frontiers in Endocrinology and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.